Addressing Health Inequities in Cancer

In early 2024, we announced a commitment of $5 million in grant funding to support additional health equity programs globally.

In the U.S., we have awarded a total of $3 million to two coalitions, made up of seven community partners, working to increase clinical trial access and participation in communities of color. They will provide services designed to address and overcome challenges with innovative practices and a plan for sustainability.

Additionally, we are awarding a total of $3.15 million to 22 organizations that are supporting the metastatic breast cancer community. These organizations will provide services for patients and caregivers to increase patient centered decision making and supportive care.

In Australia, Canada and Europe, we are providing a total of $2 million to 29 grassroots organizations that support people impacted by metastatic breast cancer (mBC). The grants fund projects that support:

• Person-centered care to improve health literacy and shared decision-making
• Organizational capacity-building to help improve disease awareness and the ability of impacted communities to provide critical support
• Resources for caregivers to improve their ability to support people living with mBC

To date, Gilead has awarded more than $22 million in health equity-related oncology grants for programs that advance health equity for disinvested communities.